Pay in 4 interest-free payments of $28.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients
female AHH/R rats) treatment inhibits subsequent phorbol ester-induced edema in rats demonstrating the systemic efficacy of the compound to inhibit PKC-driven responses
and 4 days) has a inhibitory effect on Caki-1 and ACHN cells with WTAP overexpression by CCK8 assays
3-e]pyrimido[5
PF-670462 also causes a redistribution of the GFP signal to the cytoplasm in a concentration-dependent manner
M2I-1 Catalog No.:M7256-10 A phase I trial andM2I 1 a small Mad2 inhibitor 1. Product information CAS Number: 312271 03 7 Molecular Weight: 404. 48 Formula: C19H24N4O4S Synonym: M2I 1 Chemical Name: 5 (4 (Diisobutylamino) 3 nitrobenzylidene) 2 thioxodihydropyrimidine 4,6(1H,5H) dione Smiles: CC(C)CN(CC(C)C)C1=CC=C(C=C2C(=O)NC(=S)NC2=O)C=C1[N+]([O ])=O InChiKey: BWEKPQUKWLNUKX UHFFFAOYSA N InChi: InChI=1S C19H24N4O4S c1 11(2)9 22(10 12(3)4)15 6 5 13(8 16(15)23(26)27)7 14 17(24)20 19(28)21 18(14)25
US$ 72.50
US$ 4250.00
US$ 1875.00
US$ 228.75
US$ 1725.00
US$ 94.50
US$ 97.50
US$ 132.50
US$ 287.50
US$ 177.50